Overview
4-HO-DPT (4-hydroxy-N,N-dipropyltryptamine) is a synthetic psychedelic tryptamine and the 4-hydroxy analog of DPT (N,N-dipropyltryptamine). It belongs to the broader family of 4-substituted tryptamines that includes psilocin (4-HO-DMT), 4-HO-MET, and 4-HO-DiPT. The compound is produced by introducing a hydroxyl group at the 4-position of the indole ring of DPT .
4-HO-DPT combines structural features of two distinct pharmacological lineages: the 4-hydroxytryptamine series (whose most prominent member is psilocin) and the dipropyltryptamine series (exemplified by DPT, which has seen limited use in psychotherapy and religious contexts). The compound has a very low history of human use and remains one of the more obscure members of the synthetic tryptamine catalog .
Recent receptor binding studies have shown that compared to psilocin, 4-HO-DPT displays greater activity at the 5-HT2A receptor with reduced off-target activity at the 5-HT2B receptor — a pharmacological profile that may be of interest for drug development, given that 5-HT2B agonism is associated with cardiac valvulopathy risk .
References
- Shulgin A, Shulgin A. TiHKAL: The Continuation. Transform Press, 1997.
- Klein AK, et al. Investigation of the structure-activity relationships of psilocybin analogues. ACS Pharmacol Transl Sci. 2021;4(2):533-542.
Safety at a Glance
High Risk- It is strongly recommended that one use harm reduction practices when using this drug.
- HO-not habit-forming, and the desire to use it can actually decrease with regular consumption. Like with most psyched...
- Toxicity: The toxicity and long-term health effects of recreational 4-HO-DPT use do not seem to have been studied in any scient...
- Overdose risk: Fatal overdose from 4-HO-DPT alone, at doses within the typical recreational range, is extremely ...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
oral
Duration
insufflated
Total: 4 hrs – 6 hrsoral
Total: 5 hrs – 8 hrsHow It Feels
The onset of 4-HO-DPT is slow and deliberate, building over forty-five minutes to an hour with a gravity that signals something substantial approaching. A deep, diffuse body buzz spreads through the torso, heavy and electric, while nausea builds more insistently than with lighter tryptamines. There is a gradual darkening of mood — not depression, exactly, but a solemn quality, as though the mind is preparing itself for something serious. Colors begin to deepen and saturate, shadows thicken, and the visual field takes on a moody, almost cinematic quality.
As the come-up progresses, the depth of the experience becomes apparent. Visual distortions emerge with considerable intensity: surfaces undulate and flow, patterns ripple through textures with a complexity that suggests intelligence or design, and closed-eye visuals plunge into vast, dark, intricately structured spaces. The visual palette tends toward the rich and somber — deep purples, dark golds, blacks that shimmer with hidden color. The geometry is complex and layered, suggesting alien architecture or biological structures seen at impossible magnification. Sounds become resonant and meaningful, each one seeming to carry weight and significance.
The peak is long and formidable, establishing itself around two hours in and persisting for three to five hours. This is where 4-HO-DPT distinguishes itself from lighter tryptamines: the depth of psychological engagement is extraordinary. The mind is drawn into territories of memory, meaning, and identity that are usually accessible only in the deepest psychedelic states. Ego dissolution is common at higher doses, arriving not as a gentle softening but as a fundamental dismantling. Many report encounters with what feels like transcendent intelligence, or moments of illumination where complex truths about self and existence are apprehended directly, without the mediation of language. The body may feel alternately absent and overwhelming — waves of sensation that are difficult to categorize as either pleasant or unpleasant.
The descent from 4-HO-DPT is extended and contemplative, spanning three to four hours. The intensity slowly ebbs, leaving behind a raw, opened quality — as though layers of psychological armor have been peeled away. Physical exhaustion is significant. The afterglow can last days and often carries a complex emotional character: gratitude mixed with awe, relief mixed with the lingering echo of whatever truths were encountered at the peak. The total experience spans eight to twelve hours, making it exceptionally long for a tryptamine, and demands both preparation and integration.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Cognitive & Perceptual Effects
Visual(2)
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Magnification— A visual distortion in which objects appear larger or closer than they actually are, as though one's...
Cognitive(7)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Mania— Abnormally elevated mood, energy, and activity with impulsive behavior and grandiosity, associated w...
- Panic attack— A panic attack is a discrete episode of acute, overwhelming fear or terror that arises suddenly and ...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
Transpersonal(1)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
Pharmacology
Pharmacology
Mechanism of Action
4-HO-DPT acts as a partial agonist at the serotonin 5-HT2A receptor, the primary molecular target responsible for the perceptual and cognitive effects of classical psychedelics. Like other 4-hydroxytryptamines, it is structurally related to the endogenous neurotransmitter serotonin and competes for binding at the orthosteric site of 5-HT2A .
Receptor Binding Profile
Structure-activity relationship studies comparing 4-hydroxytryptamines with varying N-alkyl substituents have revealed that 4-HO-DPT is more active at the 5-HT2A receptor than psilocin, while exhibiting less off-target activity at the 5-HT2B receptor. This selectivity profile is pharmacologically significant: chronic 5-HT2B agonism is linked to cardiac valve fibrosis (as seen with fenfluramine and ergot-derived drugs), so compounds with reduced 5-HT2B engagement may carry a more favorable safety profile .
Comparison to DPT
The parent compound DPT (without the 4-hydroxy group) has been studied more extensively. Fantegrossi et al. (2008) demonstrated that DPT's behavioral effects in rodent models are strongly mediated by the 5-HT2A receptor, with significant attenuation by the selective antagonist M100907, while the 5-HT1A antagonist WAY-100635 also showed modulatory effects — suggesting a dual 5-HT2A/5-HT1A mechanism . The addition of a 4-hydroxy group in 4-HO-DPT likely modifies the balance of activity across these receptor targets.
Duration
Behavioral data from head-twitch response assays in mice show that 4-HO-DPT's activity declines rapidly within the first 10 minutes, suggesting a relatively short duration of action compared to other tryptamines in the series .
References
- Ray TS. Psychedelics and the human receptorome. PLoS ONE. 2010;5(2):e9019.
- Klein AK, et al. Investigation of the structure-activity relationships of psilocybin analogues. ACS Pharmacol Transl Sci. 2021;4(2):533-542.
- Fantegrossi WE, et al. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT). Pharmacol Biochem Behav. 2008;88(3):358-365.
Detection Methods
Urine Detection
4-HO-DPT is not targeted by standard immunoassay-based urine drug screens. Specialized LC-MS/MS methods can detect 4-substituted tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The detection window is relatively short compared to many other drug classes due to the rapid hepatic metabolism and renal clearance of tryptamine compounds. Psilocin (4-HO-DMT) is the most commonly targeted analyte in specialized tryptamine panels, and structural analogs may or may not be captured depending on the specific method.
Blood and Serum Detection
Blood detection windows for 4-HO-DPT are short, typically 4 to 12 hours after oral ingestion. Peak plasma concentrations of the active metabolite occur within 1 to 2 hours. The rapid first-pass metabolism means that parent compound concentrations in blood are often negligible for 4-AcO prodrugs, while 4-HO compounds themselves are measured directly. LC-MS/MS is required for reliable serum detection at the low concentrations involved.
Standard Drug Panel Inclusion
4-HO-DPT is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for any of the standard panel analytes (amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, benzodiazepines, or barbiturates). Detection requires a specific request for tryptamine or novel psychoactive substance testing at a reference laboratory. Some extended forensic panels include psilocin, which may capture certain 4-substituted tryptamines, but this coverage is not guaranteed for all structural variants.
Confirmatory Methods
Confirmatory identification of 4-HO-DPT relies on LC-MS/MS with reference standards specific to the compound or its expected metabolites. GC-MS can also be used following appropriate derivatization. Immunoassay-based methods for psilocybin and psilocin exist but show variable cross-reactivity with structural analogs and are not considered reliable for novel 4-substituted tryptamines. Reference laboratories specializing in novel psychoactive substances offer the most comprehensive detection capabilities.
Reagent Testing (Harm Reduction)
The Ehrlich reagent is the primary harm reduction tool for 4-HO-DPT. A sample placed on the reagent should produce a purple to violet color change, confirming the presence of an indole ring system characteristic of tryptamines. This reaction is shared with LSD, psilocybin, DMT, and all indole-containing compounds, so it confirms the general class but not the specific identity. The Hofmann reagent provides a confirmatory blue to violet reaction for tryptamines. The Marquis reagent typically shows no reaction or a dark brown discoloration with 4-substituted tryptamines. A positive Ehrlich result significantly reduces the probability that the substance is a dangerous substitute such as an NBOMe compound.
Interactions
| Substance | Status | Note |
|---|---|---|
| 3-FMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-MMC | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 8-Chlorotheophylline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Adrafinil | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Anandamide | Caution | Cannabis can unpredictably intensify psychedelic effects and increase anxiety |
| Cannabis | Uncertain | — |
| 1,3-Butanediol | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 25E-NBOH | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T-2 | Low Risk & Synergy | Cross-tolerance exists; effects compound |
History
The history of 4-HO-DPT is intertwined with the broader story of psychedelic research, which has oscillated between periods of intense scientific interest and strict prohibition.
Like many psychedelic compounds, 4-HO-DPT was either synthesized in a laboratory setting or identified as a naturally occurring psychoactive substance through ethnobotanical research. The mid-20th century saw an explosion of interest in psychedelic compounds, with researchers exploring their potential applications in psychotherapy, creativity enhancement, and the study of consciousness.
The political and cultural backlash of the late 1960s and early 1970s led to the criminalization of most psychedelic substances, effectively halting legitimate research for decades. The resurgence of psychedelic research beginning in the 2000s — often called the "psychedelic renaissance" — has renewed scientific interest in this class of compounds, with clinical trials exploring applications in treatment-resistant depression, PTSD, end-of-life anxiety, and addiction.
4-HO-DPT exists within this broader pharmacological and cultural context, with its specific history shaped by its date of discovery, legal status, availability, and unique pharmacological profile.
Harm Reduction
It is strongly recommended that one use harm reduction practices when using this drug.
4-HO-not habit-forming, and the desire to use it can actually decrease with regular consumption. Like with most psychedelics, it is most often thought to be self-regulating.
Tolerance to the effects of 4-HO-almost immediately after ingestion. After that,37 days to be back at baseline (in the absence of further consumption). 4-HO-DPT presents cross-tolerance with Cross-all psychedelics, meaning that after the consumption of 4-HO-DPT all psychedelics will have a reduced effect.
Due to its relative obscurity, 4-HO-DPT is unscheduled in most countries.
Germany: 4-HO-DPT is controlled under the NpSG (New Psychoactive Substances Act) as of July 18, 2019. Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable. The legislator considers it possible that orders of 4-HO-DPT are punishable as an incitement to place it on the market.
Sweden: 4-HO-DPT is classified as a "dangerous substance", which means it requires a special permit to buy or sell. It is, however, not yet classified as a drug.
Switzerland: 4-HO-DPT is not controlled under Buchstabe A, B, C and D. It could be considered legal.
United Kingdom: 4-HO-DPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.
United States: 4-HO-DPT is unscheduled in the United States. It may be considered an analogue of psilocin (which is a Schedule I drug under the Controlled Substances Act). As such, the sale for human consumption or could be prosecuted as crimes under the Federal Analogue Act.
Respon
Toxicity & Safety
The toxicity and long-term health effects of recreational 4-HO-DPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 4-HO-DPT is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried 4-HO-DPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
It is strongly recommended that one use harm reduction practices when using this drug.
Tolerance and addiction potential
4-HO-DPT is not habit-forming, and the desire to use it can actually decrease with regular consumption. Like with most psychedelics, it is most often thought to be self-regulating.
Tolerance to the effects of 4-HO-DPT is built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). 4-HO-DPT presents cross-tolerance with all psychedelics, meaning that after the consumption of 4-HO-DPT all psychedelics will have a reduced effect.
Dangerous interactions
Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).
Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.
Lithium - Lithium is commonly prescribed for the treatment of bipolar disorder. There is a large body of anecdotal evidence that suggests taking it with psychedelics significantly increases the risk of psychosis and seizures. As a result, this combination is strictly discouraged.
Cannabis - Cannabis may have an unexpectedly strong and unpredictable synergy with the effects of 4-HO-DPT. Caution is advised with this combination as it can significantly increase the risk of adverse psychological reactions like anxiety, paranoia, panic attacks, and psychosis. Users are advised to start off with only a fraction of their normal cannabis dose and take long breaks between hits to avoid unintentional overdose.
Stimulants - Stimulants like amphetamine, cocaine or methylphenidate affect many parts of the brain and alter dopaminergic function. This combination can increase the risk of anxiety, paranoia, panic attacks, and thought loops. This interaction may also result in an elevated risk of mania and psychosis.
Tramadol - Tramadol is well-documented to lower the seizure threshold and psychedelics may act to trigger seizures in susceptible individuals.
Addiction Potential
not habit-forming
Overdose Information
Fatal overdose from 4-HO-DPT alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.
However, psychological emergencies can occur and require appropriate response:
- Severe anxiety, panic, or psychotic episodes
- Dangerous behavior due to impaired reality testing
- Self-harm in the context of a distressing experience
Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.
Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.
Tolerance
| Full | almost immediately after ingestion |
| Half | 3 days |
| Zero | 7 days |
Cross-tolerances
Legal Status
Due to its relative obscurity, 4-HO-DPT is unscheduled in most countries.
Germany: 4-HO-DPT is controlled under the NpSG (New Psychoactive Substances Act) as of July 18, 2019. Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable. The legislator considers it possible that orders of 4-HO-DPT are punishable as an incitement to place it on the market.
Sweden: 4-HO-DPT is classified as a "dangerous substance", which means it requires a special permit to buy or sell. It is, however, not yet classified as a drug.
Switzerland: 4-HO-DPT is not controlled under Buchstabe A, B, C and D. It could be considered legal.
United Kingdom: 4-HO-DPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.
United States: 4-HO-DPT is unscheduled in the United States. It may be considered an analogue of psilocin (which is a Schedule I drug under the Controlled Substances Act). As such, the sale for human consumption or could be prosecuted as crimes under the Federal Analogue Act.
Responsible use
Research chemical
DPT
4-HO-DMT
Tryptamine
4-HO-DPT (Wikipedia)
4-HO-DPT (TiHKAL / Isomer Design)
4-HO-DPT (Bluelight)
Experience Reports (1)
Tips (4)
Integration is just as important as the experience itself. After using 4-HO-DPT, take time to journal, reflect, or discuss the experience. Insights from psychedelic states can be powerful but need conscious effort to apply to daily life.
Psychedelic tolerance builds rapidly. Wait at least 1-2 weeks between uses of 4-HO-DPT for full tolerance reset. Taking the same dose the next day would require roughly double the amount for comparable effects.
People with a personal or family history of psychotic disorders (schizophrenia, bipolar type I) should avoid 4-HO-DPT and other psychedelics. These substances can trigger or exacerbate psychotic episodes in predisposed individuals.
Start with a low dose of 4-HO-DPT if it is your first time. You can always take more next time but you cannot take less once ingested. The difference between a comfortable and an overwhelming experience can be surprisingly small.
See Also
References (4)
- Psilocybin produces substantial and sustained decreases in depression and anxiety — Griffiths et al. Journal of Psychopharmacology (2016)paper
- Neural correlates of the LSD experience revealed by multimodal neuroimaging — Carhart-Harris et al. PNAS (2016)paper
- 4-HO-DPT - TripSit Factsheet
TripSit factsheet for 4-HO-DPT
tripsit - 4-HO-DPT - Wikipedia
Wikipedia article on 4-HO-DPT
wikipedia